The City of Rochester, Minn. will offer approximately $189.3 million in bonds for improvements at facilities of the Mayo Clinic.
The Mayo Clinic Center for Regenerative Biotherapeutics manufactures a wide range of products for active, early-phase clinical trials.
Dr. Ezzaddin Al Wahsh, MD, MBA, is a notable physician and clinical informatics specialist with a robust career spanning over ...
Match Day, held each March, is the moment when graduating medical school students across the country learn where — and in ...
Becker’s asked C-suite executives from hospitals and health systems across the U.S. to share their biggest lesson from the ...
Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale ...
Senator Amy Klobuchar paid a visit to Rochester on Monday, using it as a backdrop to stress the importance of supporting ...
The University of Minnesota and Mayo Clinic are the largest NIH grant recipients in the state. On Monday, Klobuchar spoke at ...
Colorectal cancer is a term that combines both colon and rectal cancers. The colon and rectum are two different parts of the ...
The Mayo Clinic, a nonprofit healthcare organization focused on research, education and innovation, recently announced a $1.9 billion investment into its Phoenix healthcare campus as part of its ...
When you sit down with Abridge Founder and CEO Shiv Rao, MD, you might expect the high-octane energy of a tech entrepreneur — the fast-talking, restless ambition behind a fast-growing startup.
Mayo Clinic researchers have found a new way to more precisely detect and monitor brain cell activity during deep brain stimulation, a common treatment for movement disorders such as Parkinson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback